Shares of Aurobindo Pharma rose as much as 5.6 per cent to Rs 722, their biggest intraday percentage gain since July 19.
Shares of India's third largest drugmaker by sales were the top percentage gainers on the NSE index.
The company had reported a 11 per cent fall in quarterly profit on Wednesday, hurt by lower sales from formulations business in the US and disruptions related to the launch of Goods and Services Tax in India.
Aurobindo Pharma results were mixed but were better than peers as the company reported improvements in gross margins due to its product mix, analysts from brokerage Nirmal Bang said, adding that management seemed confident of its US and overall growth.